Option Care Health, Inc. (OPCH) News
Follow Option Care Health, Inc. (OPCH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 23 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy
New On The Block Caribou Biosciences, Inc. (NASDAQ: CRBU ), a clinical-stage CRISPR genome-editing biopharmaceutical company, is exploring strategic alternatives to maximize stockholder value and plans to discontinue fur
LIVE | Oct 09, 2026, 07:03 PM UTC
H
Crude Oil Edges Lower; Lamb Weston Shares Surge Following Upbeat Q1 Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones index surging around 350 points on Tuesday. The Dow traded up 0.69% to 51,622.17 while the NASDAQ jumped 0.79% to 27,694.08. The S&P 500 also rose, gai
LIVE | Oct 06, 2026, 04:04 PM UTC
H
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday. Shares of Apogee Enterprises Inc (NASDAQ: APOG ) rose sharply after the company announced better-than-expected second-quarter financia
LIVE | Oct 06, 2026, 02:20 PM UTC
M
CD&R, McKesson to Acquire Option Care Health for $5.8B
CD&R and McKesson are acquiring Option Care Health, an at-home infusion therapy provider, for approximately $5.8 billion, including debt. CD&R will hold a majority interest of about 51%.
EQUITY | Oct 06, 2026, 12:41 PM UTC
H
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Doubles Down on Iran Pressure— OPCH, PCVX, STZ in Focus (UPDATED)
Editor’s Note: The ETFs tracking benchmark indices and the headline were updated in the story. U.S. stock futures traded higher on Tuesday, with futures tied to the Dow Jones, S&P 500 and Nasdaq 100 pointing to gains aft
LIVE | Oct 06, 2026, 12:28 PM UTC
M
CD&R, McKesson Sign Deal to Acquire Option Care Health
CD&R and McKesson Corporation have entered into an agreement to acquire Option Care Health.
EQUITY | Oct 06, 2026, 12:11 PM UTC
H
Option Care Health agreed to be acquired for $32.05 per share
Option Care Health agreed to be acquired by CD&R and McKesson for $32.05 per share, valuing the company at about $5.8B enterprise value, with closing expected in H1 2027 pending approvals.
MNA | Oct 06, 2026, 12:01 PM UTC
H
Stock Market Today: S&P 500, Dow Jones Futures Gain as Scott Bessent Doubles Down on Iran Pressure— OPCH, PCVX, STZ in Focus
U.S. stock futures traded higher on Tuesday, with futures tied to the Dow Jones, S&P 500 and Nasdaq 100 pointing to gains after the major averages closed higher on Monday. Iran’s economic crisis escalated as Oil Minister
LIVE | Oct 06, 2026, 09:22 AM UTC
H
Option Care Health Stock Surges on $5B McKesson Buyout Talks
Option Care Health (OPCH) shares surged approximately 22% in after-hours trading following a report that McKesson (MCK) and private equity firm Clayton Dubilier & Rice are nearing a deal for a buyout valued at over $5 bi
MNA | Oct 05, 2026, 10:28 PM UTC
H
Option Care Health Surges on Report of Potential $5 Billion Takeover Bid
Option Care Health shares jumped 22% in after-hours trading following a Financial Times report that healthcare giant McKesson and a private-equity firm are nearing a deal to acquire the home and outpatient infusion thera
MNA | Oct 05, 2026, 09:17 PM UTC
L
OPCH: Growth in acute and specialty therapies, portfolio diversification, and new rare drugs drive momentum
Momentum has stabilized with growth in acute and specialty therapies, supported by a diversified portfolio and strong hospital partnerships. Biosimilar competition and new rare therapies are expected to drive future grow
NEWS | Sep 15, 2026, 04:16 PM UTC
L
OPCH: Growth momentum, portfolio diversification, and new therapies drive future opportunities
Momentum has stabilized with growth in both acute and specialty therapies, supported by a diversified portfolio and strong hospital relationships. Biosimilar competition and new rare/orphan therapies are expected to driv
NEWS | Sep 15, 2026, 03:52 PM UTC
L
OPCH - Option Care Health to Participate in Upcoming Investor Conferences
OPCH - Option Care Health to Participate in Upcoming Investor Conferences
EQUITY | Sep 02, 2026, 08:05 PM UTC
H
OPCH Downgraded to Hold at Deutsche Bank
Deutsche Bank downgrades OPCH
EQUITY | Jul 30, 2026, 12:01 PM UTC
H
Some earnings movers to upside from today, premarket: AVTR +13% LFUS +11% GEHC +9% GNRC +9% HAYW +8% OPCH +6% APH +6% QURE +6% E +6%
Some earnings movers to upside from today, premarket: AVTR +13% LFUS +11% GEHC +9% GNRC +9% HAYW +8% OPCH +6% APH +6% QURE +6% E +6%
EARNINGS | Jul 29, 2026, 12:58 PM UTC
L
OPCH - Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
OPCH - Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
EARNINGS | Jul 29, 2026, 11:00 AM UTC
L
OPCH Option Care Health - RESULTS: Q2, Q2 net REV rises 1.9% to $1.44B - SEC filing, Q2 ADJ diluted EPS up 9.8% to $0.45 - SEC filing, Optio
OPCH Option Care Health - RESULTS: Q2, Q2 net REV rises 1.9% to $1.44B - SEC filing, Q2 ADJ diluted EPS up 9.8% to $0.45 - SEC filing, Option Care Health - Earnings Notes:, Sees FY2026 ADJ diluted EPS $1.85-$1.92 - SEC f
EARNINGS | Jul 29, 2026, 10:59 AM UTC
L
Option Care Health Raises FY2026 Adj EPS Guidance from $1.82-$1.92 to $1.85-$1.92 vs $1.84 Est; Affirms FY2026 Sales Guidance of $5.675B-$5.
Option Care Health (NASDAQ: OPCH ) raises FY2026 Adj EPS guidance from $1.82-$1.92 to $1.85-$1.92 vs $1.84 analyst estimate. Affirms FY2026 sales outlook from $5.675 billion-$5.775 billion to $5.675 billion-$5.775 billio
EARNINGS | Jul 29, 2026, 10:57 AM UTC
L
Apple upgraded, Brinker initiated: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: HSBC upgraded Apple (AAPL) to Buy
EQUITY | Jul 17, 2026, 01:43 PM UTC
L
early moves among today's downgrades NFLX -11.3%, OPCH -2.0%, SAH -1.7%, KREF -1.6%, ATAI -0.6%, AGNC -0.3%, OKE +0.1%, DSGR +0.9% early mov
early moves among today's downgrades NFLX -11.3%, OPCH -2.0%, SAH -1.7%, KREF -1.6%, ATAI -0.6%, AGNC -0.3%, OKE +0.1%, DSGR +0.9% early moves among today's negative initiations - none
EQUITY | Jul 17, 2026, 12:00 PM UTC
L
OPCH Downgrade from Overweight to Equal Weight W/$24.00 PT at Stephens
OPCH Downgrade from Overweight to Equal Weight W/$24.00 PT at Stephens
EQUITY | Jul 17, 2026, 11:56 AM UTC
L
OPCH downgraded from Overweight to Equal Weight W/ $24 PT (from $30) @ Stephens
OPCH downgraded from Overweight to Equal Weight W/ $24 PT (from $30) @ Stephens
EQUITY | Jul 17, 2026, 11:20 AM UTC
H
Option Care Health downgraded at Stephens on low earnings visibility
As previously reported,...
EQUITY | Jul 17, 2026, 10:14 AM UTC